Interestingly, DNA methyltransferase 1 (DNMT1) can translocate into the mitochondria and thereby contribute to the hypermethylation of the mtDNA during MASLD progression because MASH patients show an increased expression of DNMT1 [25,26]. Here, DNMT1 is linked to metabolic dysfunction-associated steatotic liver disease.